Open AccessFungal Infections Associated With the Use of Novel Immunotherapeutic Agents
Author(s) -
Marilia Bernardes,
Tobias M. Hohl
Publication year - 2020
Publication title -
current clinical microbiology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.657
H-Index - 16
ISSN - 2196-5471
DOI - 10.1007/s40588-020-00154-4
Subject(s) - aspergillosis , immunotherapy , neutropenia , cytokine release syndrome , immunology , chimeric antigen receptor , medicine , pneumonia , immune system , adverse effect , intensive care medicine , chemotherapy
Recent concerns have emerged regarding the potential of immunotherapy to cause infection. In this review, we summarize the current literature on invasive fungal infections that occur during treatment with immune checkpoint inhibitors and chimeric antigen receptor T cell therapy.